April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Smoking as a Risk Factor for Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome
Author Affiliations & Notes
  • Lena V. Chheda
    Ophthalmology,
    The Ohio State University, Columbus, Ohio
  • Amy K. Ferketich
    Epidemiology,
    The Ohio State University, Columbus, Ohio
  • Charles P. Carroll
    Ophthalmology,
    The Ohio State University, Columbus, Ohio
  • Paul D. Moyer
    Ophthalmology,
    The Ohio State University, Columbus, Ohio
  • Daryl E. Kurz
    Ophthalmology,
    The Ohio State University, Columbus, Ohio
  • Paul A. Kurz
    Ophthalmology,
    The Ohio State University, Columbus, Ohio
  • Footnotes
    Commercial Relationships  Lena V. Chheda, None; Amy K. Ferketich, None; Charles P. Carroll, None; Paul D. Moyer, None; Daryl E. Kurz, None; Paul A. Kurz, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3609. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lena V. Chheda, Amy K. Ferketich, Charles P. Carroll, Paul D. Moyer, Daryl E. Kurz, Paul A. Kurz; Smoking as a Risk Factor for Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3609.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine whether smoking is a risk factor for the development of choroidal neovascularization (CNV) in patients with presumed ocular histoplasmosis syndrome (POHS).

Methods: : Retrospective case-control study. Following IRB approval, a medical record review was performed for 568 patients within the age range of 18-50 years. Data was first collected on all 142 patients diagnosed with CNV secondary to POHS in a private retina practice between 7/1/2000 and 8/1/2010. Age, gender, zip code, diagnosis date, insurance status, and smoking status at the time of diagnosis were recorded. Data was then collected on 426 randomly selected patients (age 18-50) from a private comprehensive ophthalmology practice at the same location. Age, gender, zip code, date of visit, reason for visit, insurance status, and smoking status were recorded. For each of the 142 POHS patients, 3 comprehensive clinic patients (whose date of visit was within a 3-month window on either side of the date of CNV diagnosis in the corresponding POHS patient) served as controls. Using the recorded data, descriptive statistics were calculated for cases and controls. Univariate odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression. Variables that were significant in the univariate analyses were examined in a multivariable model. Those variables that were not significant were removed one at a time, in order of the least significance.

Results: : The mean age of POHS patients afflicted with CNV was 39±7.1 years, while that of the control patients was 35.7±9.1 years. Of the patients with CNV secondary to POHS, 47.2% were current/former smokers (42.3% current, 4.9% former). Of the control patients, 22.5% were current/former smokers (21.8% current, 0.7% former). Age, insurance status, and smoking status were significant in the univariate models. In the final adjusted logistic regression model, only age (OR 1.04, 95% CI, 1.02-1.07) and smoking status (OR 3.01, 95% CI, 2.01-4.52) were significant.

Conclusions: : The odds of a smoker developing CNV secondary to POHS are approximately 3 times that of a nonsmoker.

Keywords: clinical (human) or epidemiologic studies: risk factor assessment • choroid: neovascularization • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×